Clinical Research Directory

Inclusion Criteria: * 1\. Diagnosed bladder cancer: The patient needs to be diagnosed with bladder cancer through pathological examination and have undergone bladder cancer surgery. * 2\. Planned to receive bladder infusion therapy: Patients need to plan to receive bladder infusion therapy after surgery and agree to participate in the study. * 3\. Age range: 18 to 75 years old. * 4\. Normal blood, liver and kidney function: Laboratory tests showed that the patient's blood routine, liver function and kidney function were within the normal range. * 5\. Signed informed consent: The patient understands the content of the study and voluntarily signs the informed consent. Exclusion Criteria: * 1\. Serious comorbidities: including but not limited to heart disease, severe liver and kidney insufficiency, uncontrolled hypertension, diabetes, etc. * 2\. History of allergies: Patients with a known history of allergy to krill oil or perfusion drug components. * 3\. History of prior chemotherapy: Patients who have received perfusion therapy prior to this study. * 4\. History of other malignant tumors: Patients with a history of other malignant tumors. * 5\. Pregnancy or lactation: Female patients who are pregnant or lactating. * 6\. Psychiatric illness: Patients with a history of severe psychiatric illness or currently receiving treatment for psychiatric illness. * 7\. Poor study compliance: Patients who believe that they are unable to complete the entire trial process as required by the study. * 8\. Other: Other conditions that the investigator considers unsuitable to participate in this study.